Suchergebnisse - "Goletti, Delia"

PubPharm (15)

1

Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics : An observational cohort 10-year study from the BIOPURE registry

enthalten in: European journal of clinical investigation | 2023

von Fornaro, M. | Stano, S. | Goletti, D. | +8

2

Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis : 2021 updated ITABIO statements

enthalten in: Expert opinion on drug safety | 2022

von Cantini, F. | Goletti, D. | Benucci, M. | +3

3

Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis

enthalten in: Frontiers in immunology | 2022

von Farroni, C. | Picchianti-Diamanti, A. | Aiello, A. | +23

4

Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases

enthalten in: Expert opinion on drug safety | 2020

von Cantini, F. | Blandizzi, C. | Niccoli, L. | +2

5

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

6

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

enthalten in: Expert review of anti-infective therapy | 2018

von Goletti, D. | Petrone, L. | Ippolito, G. | +3

7

Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

enthalten in: Seminars in arthritis and rheumatism | 2017

von Cantini, F. | Niccoli, L. | Nannini, C. | +10

8

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Bonovas, S. | Minozzi, S. | Lytras, T. | +13

9

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Minozzi, S. | Bonovas, S. | Lytras, T. | +14

10

Influence of anti-TNF immunogenicity on safety in rheumatic disease : a narrative review

enthalten in: Expert opinion on drug safety | 2016

von Matucci, A. | Cammelli, D. | Cantini, F. | +7